Sana Biotechnology, Inc.
SANA
$3.20
-$0.06-1.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 44.27M | 44.30M | 49.39M | 53.15M | 59.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 180.06M | 190.96M | 190.20M | 206.22M | 214.90M |
| Operating Income | -180.06M | -190.96M | -190.20M | -206.22M | -214.90M |
| Income Before Tax | -241.99M | -244.17M | -234.41M | -252.18M | -208.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -241.99 | -244.17 | -234.41 | -252.18 | -208.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -241.99M | -244.17M | -234.41M | -252.18M | -208.67M |
| EBIT | -180.06M | -190.96M | -190.20M | -206.22M | -214.90M |
| EBITDA | -168.57M | -178.21M | -176.70M | -191.85M | -199.49M |
| EPS Basic | -0.94 | -0.98 | -0.97 | -1.06 | -0.88 |
| Normalized Basic EPS | -0.41 | -0.45 | -0.46 | -0.52 | -0.55 |
| EPS Diluted | -0.94 | -0.98 | -0.97 | -1.06 | -0.88 |
| Normalized Diluted EPS | -0.41 | -0.45 | -0.46 | -0.52 | -0.55 |
| Average Basic Shares Outstanding | 1.05B | 1.01B | 972.78M | 947.70M | 943.73M |
| Average Diluted Shares Outstanding | 1.05B | 1.01B | 972.78M | 947.70M | 943.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |